Rare tumors: an eye on the future.

M. Sagoo,A. Filipović,Lamis Al Harby,J. Stebbing

DOI: https://doi.org/10.2217/fon.15.212

2015-09-08

Future Oncology

Abstract:Ocular Oncology Service, Moorfields Eye Hospital, London, UK St Bartholomew’s Hospital, London, UK UCL Institute of Ophthalmology, London, UK Department of Oncology, Imperial College, London, UK *Author for correspondence: j.stebbing@imperial.ac.uk

What problem does this paper attempt to address?

Neural cell recognition molecule F11: Homology with fibronectin type III and immunoglobulin type C domains

T. Brümmendorf,J. Wolff,R. Frank,F. Rathjen

DOI: https://doi.org/10.1016/0896-6273(89)90073-1

IF: 16.2

1989-04-01

Neuron

Abstract:
Diabetes mellitus and hearing loss: A review

Dorit Samocha-Bonet,Buffy Wu,David K Ryugo,David K. Ryugo

DOI: https://doi.org/10.1016/j.arr.2021.101423

IF: 11.788

2021-11-01

Ageing Research Reviews

Abstract:Diabetes (type 2) and sensorineural hearing loss are common health problems manifested with ageing. While both type 1 and type 2 diabetes have been associated with hearing loss, a causal link has been difficult to establish. Individuals with diabetes have twice the incidence of hearing loss compared to those without diabetes and those with prediabetes have a 30% higher rate of hearing loss. Whether hearing loss is associated with diabetes independent of glycemic control remains to be determined. Hearing loss has its own set of risk factors and shares others with diabetes. This review will summarize the complex relationship between diabetes and sensorineural hearing loss.

cell biology,geriatrics & gerontology,gerontology
AIDS, acyclovir and apocalypse.

N. Goodman

British Journal of Hospital Medicine

Abstract:
Epidemiology of Diabetes and Hearing Loss

Rachael R Baiduc,Elizabeth P Helzner,Rachael R. Baiduc,Elizabeth P. Helzner

DOI: https://doi.org/10.1055/s-0039-1697643

2019-10-09

Seminars in Hearing

Abstract:Abstract Hearing loss is a highly prevalent chronic condition. In addition to age, sex, noise exposure, and genetic predisposition, cardiovascular disease and its antecedents may precipitate hearing loss. Of emerging interest is the connection between diabetes and auditory dysfunction. Cross-sectional studies consistently suggest that prevalence of hearing loss is higher in persons with diabetes compared with those without diabetes, especially among younger persons. Furthermore, longitudinal studies have demonstrated higher incidence of hearing loss in persons with diabetes compared to those without diabetes. These findings seem to hold for both type 1 and type 2 diabetes, although considerably more population-based evidence is available for type 2 diabetes. Data on gestational diabetes and hearing outcomes are limited, as are data relating diabetes to otologic sequelae such as fungal infection. Here, we examine evidence from epidemiologic studies of diabetes and hearing loss and consider clinical and laboratory data where population-based data are lacking.
Risk Factors for Hearing Impairment Among U.S. Adults With Diabetes

Kathleen E. Bainbridge,Howard J. Hoffman,Catherine C. Cowie

DOI: https://doi.org/10.2337/dc10-2161

2011-06-17

Diabetes Care

Abstract:OBJECTIVE The objective of this study was to examine the risk factors of low/mid-frequency and high-frequency hearing impairment among a nationally representative sample of diabetic adults. RESEARCH DESIGN AND METHODS Data came from 536 participants, aged 20–69 years, with diagnosed or undiagnosed diabetes who completed audiometric testing during 1999–2004 in the National Health and Nutrition Examination Survey (NHANES). We defined hearing impairment as the pure-tone average >25 dB hearing level of pure-tone thresholds at low/mid-frequencies (500; 1,000; and 2,000 Hz) and high frequencies (3,000; 4,000; 6,000; and 8,000 Hz) and identified independent risk factors using logistic regression. RESULTS Controlling for age, race/ethnicity, and marital status, odds ratios for associations with low/mid-frequency hearing impairment were 2.20 (95% CI 1.28–3.79) for HDL <40 mg/dL and 3.55 (1.57–8.03) for poor health. Controlling for age, race/ethnicity, sex, and income-to-poverty ratio, odds ratios for associations with high-frequency hearing impairment were 4.39 (1.26–15.26) for history of coronary heart disease and 4.42 (1.26–15.45) for peripheral neuropathy. CONCLUSIONS Low HDL, coronary heart disease, peripheral neuropathy, and having poor health are potentially preventable correlates of hearing impairment for people with diabetes. Glycemic control, years since diagnosis, and type of glycemic medication were not associated with hearing impairment.

endocrinology & metabolism
1326-P: Diabetes Is Associated with a Higher Hearing Loss Risk in an Observational and Mendelian Randomization Study

TONGTONG LI,WEI GAN,CHENGWU FENG,YUNAN LIU,YAYING CAO,HAN HAN,DONGHENG FU,HUADONG XING,HAIQIANG QIN,MENG SUN,MENG WANG,GENG ZONG

DOI: https://doi.org/10.2337/db23-1326-p

IF: 7.7

2023-06-20

Diabetes

Abstract:Observational studies on diabetes and hearing loss have been controversial, and their potential causal relationship has not been investigated. We conducted Mendelian randomization (MR) analyses to determine whether type 1 diabetes (T1D), type 2 diabetes (T2D), fasting insulin (FI), 2-h glucose (2hG), fasting glucose (FG), and glycated hemoglobin (HbA1c) were associated with hearing loss. Among 497,998 individuals in the UK biobank, T1D and T2D were identified by medical history in questionnaires and clinical records. Hearing loss was primarily defined by speech-in-noise tests in the better ear (SiN hearing loss, SiNHL) and secondarily identified by International Classification of Diseases code (ICD-defined hearing loss, ICDHL) and self-reported data (hearing difficulty, HDiff; hearing difficulty with noise, HDiffn; and hearing aid use, HAid). In observational analyses, odds ratios (ORs) in people with T1D than those without diabetes were 1.27 (95% CI 1.06-1.53) for SiNHL, 1.36 (1.14-1.62) for HAid, and 1.78 (1.49-2.12) for ICDHL. The corresponding ORs in people with T2D were 1.17 (1.09-1.24), 1.16 (1.08-1.23), and 1.25 (1.16-1.34), respectively. In MR analyses, genetically predicted T1D and T2D were associated with a higher risk of SiNHL (OR 1.02 per 1-unit higher log-odds of T1D 1.02 [1.00-1.03]; T2D 1.03 [0.99-1.06]). Further analysis of glycemic traits supported an inverse association of genetically elevated FI on SiNHL (per 1-log unit increase in pmol/L FI 0.71 [0.54-0.94]), and a positive association for genetically elevated 2hG (per 1-log unit increase in mmol/L 2hG 1.18 [1.06-1.31]). Results were largely robust to sensitivity analyses accounting for horizontal pleiotropy, sample overlap, and definitions of hearing loss. Our study suggested a potential causal relationship between diabetes and hearing loss risk. The finding warrants confirmation by larger population-based studies and experimental studies on potential biological pathways. Disclosure T.Li: None. M.Sun: None. M.Wang: None. G.Zong: None. W.Gan: Employee; Novo Nordisk A/S. C.Feng: None. Y.Liu: None. Y.Cao: None. H.Han: None. D.Fu: None. H.Xing: None. H.Qin: None. Funding National Science Fund for Excellent Young Scholars (81922060)

endocrinology & metabolism
Diabetes and Risk of Hearing Impairment in Adults: A Meta-Analysis

Chika Horikawa,Satoru Kodama,Shiro Tanaka,Kazuya Fujihara,Reiko Hirasawa,Yoko Yachi,Hitoshi Shimano,Nobuhiro Yamada,Kazumi Saito,Hirohito Sone

DOI: https://doi.org/10.1210/jc.2012-2119

2013-01-01

Abstract:CONTEXT: Recently, several studies have investigated the relationship between diabetes and hearing impairment, but results were inconsistent.OBJECTIVE: Our objective was to compare the prevalence of hearing impairment between diabetic and nondiabetic adults.DATA SOURCES: We performed a systematic literature search using MEDLINE (1950 to May 30, 2011) and EMBASE (1974 to May 30, 2011).STUDY SELECTION: Cross-sectional studies were included if data on numbers of hearing-impaired and non-hearing-impaired cases with diabetes were presented. Hearing impairment was limited to that assessed by pure-tone audiometry that included at least 2 kHz of frequency range and was defined as progressive, chronic, sensorineural, or without specified cause.DATA EXTRACTION: Two authors independently extracted relevant data. Odd ratios (ORs) of hearing impairment related to diabetes calculated in each study were pooled with the random-effects model.DATA SYNTHESIS: Data were obtained from 13 eligible studies (20,194 participants and 7,377 cases). Overall pooled OR (95% confidence interval) of hearing impairment for diabetic participants compared with nondiabetic participants was 2.15 (1.72-2.68). OR was higher in younger participants (mean age, ≤60 yr) than in those over 60 yr among which the OR remained significant (2.61 and 1.58, P = 0.008). The strength of the association between diabetes and prevalence of hearing impairment was not significantly influenced by whether participants were matched for age and gender (P = 0.68) or whether participants chronically exposed to noisy environments were excluded (P = 0.19).CONCLUSIONS: Current meta-analysis suggests that the higher prevalence of hearing impairment in diabetic patients compared with nondiabetic patients was consistent regardless of age.

endocrinology & metabolism
A systematic review of the association of Type I diabetes with sensorineural hearing loss

Rahul Mittal,Keelin McKenna,Grant Keith,Joana R. N. Lemos,Jeenu Mittal,Khemraj Hirani

DOI: https://doi.org/10.1371/journal.pone.0298457

IF: 3.7

2024-02-11

PLoS ONE

Abstract:Type 1 diabetes (T1D) has been associated with several comorbidities such as ocular, renal, and cardiovascular complications. However, the effect of T1D on the auditory system and sensorineural hearing loss (SNHL) is still not clear. The aim of this study was to conduct a systematic review to evaluate whether T1D is associated with hearing impairment. The databases PubMed, Science Direct, Scopus, and EMBASE were searched in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Three reviewers independently screened, selected, and extracted data. The Joanna Briggs Institute (JBI) Critical Appraisal Tools for Analytical cross-sectional and case-control studies were used to perform quality assessment and risk of bias analysis on eligible studies. After screening a total of 463 studies, 11 eligible original articles were included in the review to analyze the effects of T1D on the auditory system. The included studies comprised cross-sectional and case-control investigations. A total of 5,792 patients were evaluated across the 11 articles included. The majority of the studies showed that T1D was associated with hearing impairment compared to controls, including differences in PTAs and OAEs, increased mean hearing thresholds, altered acoustic reflex thresholds, and problems with the medial olivocochlear (MOC) reflex inhibitory effect. Significant risk factors included older age, increased disease duration, and higher HbA1C levels. This systematic review suggests that there is a correlation between T1D and impairment on the auditory system. A multidisciplinary collaboration between endocrinologists, otolaryngologists, and audiologists will lead to early detection of hearing impairment in people with T1D resulting in early intervention and better clinical outcomes in pursuit of improving the quality of life of affected individuals. This systematic review is registered in PROSPERO (CRD42023438576).

multidisciplinary sciences
An association of type 1 diabetes mellitus with auditory dysfunction: A systematic review and meta-analysis

Zhi-Pan Teng,Rui Tian,Fen-Li Xing,Hui Tang,Jin-Jing Xu,Bing-Wen Zhang,Jian-Wei Qi

DOI: https://doi.org/10.1002/lary.26346

Abstract:Objective: To establish the relationship between the presence of type 1 diabetes mellitus (DM) and auditory dysfunction in clinical settings by a systematic review and meta-analysis of currently available published data. Data sources and review methods: The electronic databases PubMed, Embase, and Wanfang Data were searched for eligible relevant studies up to May 2016, and the reference lists of the retrieved articles were used for additional manual search. All the articles included in this pooled analysis were determined according to the preset inclusion and exclusion criteria. Meta-analysis of pooled data was performed using Review Manager 5.3. Results: A total of 15 studies were included for further combined analysis. The results showed that patients with type 1 diabetes had a significantly higher prevalence of hearing loss than controls (odds ratio = 49.08, 95% confidence interval = 12.03-200.31, P < 0.00001); standardized mean of differences (SMD) of pure tone audiometry at 4,000 Hz between diabetes and controls was 0.87 (Z = 2.22, P = 0.03, I2 = 95%); SMD of the latency time was 0.54 (Z = 2.69, P = 0.007, I2 = 78%) for waves III and 0.61 (Z = 2.38, P = 0.02, I2 = 86%) for wave V, respectively; and SMD of the interpeak latency time was 0.41 (Z = 2.84, P = 0.005, I2 = 39%) for waves I to III and 0.61 (Z = 2.67, P = 0.008, I2 = 81%) for waves I to V, respectively, between diabetics and controls. Conclusion: Our study reveals that there is relationship between the presence of type 1 DM and an increased risk for developing mild and subclinical hearing impairment. Level of evidence: NA. Laryngoscope, 127:1689-1697, 2017.
Hearing loss in type 1 diabetes: Are we facing another microvascular disease? A meta-analysis

Mario A Mujica-Mota,Neel Patel,Issam Saliba

DOI: https://doi.org/10.1016/j.ijporl.2018.07.005

Abstract:Objective: Evidence shows type 1 diabetes(T1D) leads to vascular damage and neuropathy. The purpose of this study was to perform a systematic review and a meta-analysis to assess the evidence of the effects of T1D on hearing function. Methods: Three electronic databases were used. The articles were independently reviewed by two authors using predefined inclusion criteria to identify eligible studies. They were then classified as high or low methodological quality. Meta-analysis was performed on pooled data of hearing loss(HL) prevalence, pure tone audiometry(PTA), otoacoustic emissions(OAE) and auditory brainstem response(ABR). Results: Twenty-one articles fulfilled the inclusion criteria. In all studies, HL was defined as pure tone greater than 20 dB in at least one frequency. The prevalence of HL ranged between 5.17% and 48% for diabetics, which was higher than in controls which ranged between 0% à 40% (OR = 7.7, 95% CI 3.32-17.98, p < 0.05 and I2 = 40%). The tendency of mean thresholds of PTA was higher in diabetics than in controls, with results being statistically significant at 250, 500 and 1000 Hz. OAE were significantly lower in diabetic patients. ABR latencies were longer in T1D group compared to controls and were statistical significant. Conclusions: Patients with T1D have a significantly greater prevalence of HL compared to the control group. These damages could be compared to other microvascular diseases. Further studies are needed to assess whether hearing testing should be considered as a part of the screening process in T1D patients and therefore, secondary preventive treatment may be warranted as well.
Prevalence of Hearing Loss in Type 2 Diabetes Mellitus and Its Association with Severity of Diabetic Neuropathy

Abin M Abraham,Ashish Varghese,Jubbin Jagan Jacob

DOI: https://doi.org/10.21203/rs.3.rs-1253537/v1

2022-01-14

Abstract:Abstract Purpose This study assessed the prevalence of hearing loss (HL) in patients with Type 2 Diabetes (T2DM) and its relationship with the presence and severity of diabetic neuropathy. Methods Patients between the ages of 30 to 60 years (both ages inclusive) with T2DM were recruited and divided into three groups. Group 1 included patients without neuropathy. Group 2 had patients with mild neuropathy. Group 3 had patients with moderate and severe neuropathy. After informed consent hearing threshold was assessed using pure tone audiometry (PTA). Results Of the 200 patients recruited, the prevalence of hearing loss was overall 81%. The prevalence was 66.7% in group 1, 80.9% in group 2 and 87.6% in group 3 (p=0.009). Among patients with moderate to severe neuropathy (group 3) 33.3% had clinically significant hearing loss (p=0.015). Age, gender, presence of neuropathy and severity of neuropathy were associated with increased risk of developing hearing loss. Severity of hearing loss worsened with increase in severity of neuropathy. Conclusions Age, gender and severity of neuropathy were associated with increased risk of developing hearing loss. Screening for hearing loss in patients with moderate to severe diabetic neuropathy using self-report questionnaires can help in timely diagnosis and treatment.
Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

Khalid Al-Rubeaan,Murad AlMomani,Aisha Khalaf AlGethami,Jamal Darandari,Abdulaziz Alsalhi,Dehkra AlNaqeeb,Ebtehal Almogbel,Fatima H. Almasaari,Amira M. Youssef

DOI: https://doi.org/10.5144/0256-4947.2021.171

2021-06-01

Annals of Saudi Medicine

Abstract:BACKGROUND: Hearing loss is an underestimated comorbid condition in type 2 diabetes. OBJECTIVES: Investigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss. DESIGN: Cross-sectional. SETTING: Tertiary care center, diabetes clinic. PATIENTS AND METHODS: Patients with type 2 diabetes, aged 30 to 60 years, were randomly selected to participate. All patients underwent clinical ear examinations and were referred for full audiological evaluation. Otoacoustic emission was used to assess inner function, tympanometry to assess middle-ear function, and pure tone air/bone audiometry to assess hearing sensitivity. Risk factors for hearing loss were assessed by multivariate logistic regression. MAIN OUTCOME MEASURE: Frequency, severity and risk factors for hearing loss. SAMPLE SIZE: 157 RESULTS: Of the 157 patients, 77 had hearing loss in both ears (49.0%), 13 in the right ear only (8.3%), 14 in the left ear only (8.9%), and 53 (33.8%) had normal hearing. In the 181 ears with sensorineural hearing loss, 90 had mild loss (49.7%), 69 moderate loss (38.2%), 16 severe loss (8.8%) and 6 had profound loss (3.3%). Disabling hearing loss was observed in 46 (29%) patients. A higher frequency of hearing loss was present in patients with glycated hemoglobin levels ≥8%. In the multivariate logistic regression analysis, the most important factors associated with hearing loss were longer diabetes duration, poor glycemic control and the presence of hypertension. CONCLUSIONS: Hearing loss is an underestimated comorbid condition in type 2 diabetes that warrants frequent hearing assessments and management. Strict glycemic and hypertension control is essential for the minimization of the effects of diabetes on hearing sensitivity. LIMITATIONS: Small sample size, limited age window (30-60 years), which was chosen to eliminate the natural aging effect on hearing. Cross-sectional nature was not ideal for the assessment of causality. CONFLICT OF INTEREST: None.

medicine, general & internal
RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.

K. Cruickshanks,A. Barnie,G. Lorenzi,B. Braffett,Xiaoyu Gao,C. Cowie,D. Schade,R. Gubitosi-Klug,M. Larkin,J. Lachin,K. Bainbridge,J. Kramer

DOI: https://doi.org/10.4158/EP-2019-0193

IF: 3.701

2019-08-14

Endocrine Practice

Abstract:Objective: Studies have demonstrated that HbA1c is a significant predictor of hearing impairment in type 1 diabetes. We identified additional factors associated with hearing impairment in participants with type 1 diabetes from the Diabetes Control and Complications Trial and its observational follow-up, Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Methods: 1,150 DCCT/EDIC participants were recruited for the Hearing Study. A medical history, physical measurements, and a self-administered hearing questionnaire were obtained. Audiometry was performed by study-certified personnel and assessed centrally. Logistic regression models assessed the association of risk factors and comorbidities with speech- and high-frequency hearing impairment. Results: Mean age was 55±7 years, duration of diabetes 34±5 years, and DCCT/EDIC HbA1c 7.9±0.9%. In multivariable models, higher odds of speech-frequency impairment were significantly associated with older age, higher HbA1c, history of noise exposure, male sex, and higher triglycerides. Higher odds of high-frequency impairment were associated with older age, male sex, history of noise exposure, higher skin intrinsic florescence (SIF) as a marker of tissue glycation, higher HbA1c, non-professional/non-technical occupations, sedentary activity, and lower LDL cholesterol. Among participants who previously completed computed tomography and carotid ultrasonography, coronary artery calcification (CAC)>0 and carotid intima-medial thickness were significantly associated with high- but not speech-frequency impairment. Conclusion: Consistent with previous reports, male sex, age, several metabolic factors, and noise exposure are independently associated with hearing impairment. The association with SIF further emphasizes the importance of glycemia, as a modifiable risk factor, over time. In addition, the macrovascular contribution of CAC is novel and important. Clinical Trials Registration Numbers: NCT00360893, NCT00360815.

Medicine
A clinical study of audiological profile in diabetes mellitus patients

A. Jagdish Kumar Sunkum,Srinidhi Pingile

DOI: https://doi.org/10.1007/s00405-012-2063-y

2012-06-14

Abstract:The aim of this study is to compare the hearing thresholds of the diabetic patients with the age- and sex-matched normal control group regarding age, glucose level, duration and complications of diabetes with the degree of hearing impairment. Pure tone audiometry was performed in 58 patients with type 1 and 2 diabetes mellitus and compared with 58 age- and sex-matched controls. The patients were categorized into groups according to age, duration of diabetes, complications and control of diabetes. These observations were compared with those from the control subjects. 15–50 years age group with diabetes showed a significant high frequency hearing loss, as compared to the controls. Complicated and poorly controlled diabetics have significant degree of hearing loss in high frequencies as compared to those who were well controlled and uncomplicated. There was also a correlation between the level of hearing loss and duration of diabetes.

otorhinolaryngology
Effects of chitosan-stabilized selenium nanoparticles on cell proliferation, apoptosis and cell cycle pattern in HepG2 cells: comparison with other selenospecies.

Héctor Estévez,J. Carlos Garcia-Lidon,J. Luque‐Garcia,C. Cámara

DOI: https://doi.org/10.1016/j.colsurfb.2014.06.062

2014-10-01

Abstract:
Association of different severity of diabetic retinopathy and hearing loss in type 2 diabetes mellitus

Yousef Alizadeh,Mir Mohammad Jalali,Asieh Sehati

DOI: https://doi.org/10.1016/j.amjoto.2022.103383

IF: 2.873

2022-03-01

American Journal of Otolaryngology

Abstract:PURPOSE: Microvascular involvement in patients with diabetes mellitus is one of the causes of retinopathy, nephropathy, and neuropathy. The same pathologic processes may occur in the inner ear structures. This case-control study aimed to evaluate the hearing thresholds in type 2 diabetic patients with different severity of diabetic retinopathy (DR) and to compare these findings with controls.MATERIALS AND METHODS: We evaluated the hearing threshold in four groups of eligible subjects aged 20-70 years. These groups were controls, diabetic patients with no-DR, with mild-moderate non-proliferative DR (NPDR), and with severe NPDR/proliferative DR (PDR). Each group consisted of 105 subjects. Speech-frequency and high-frequency hearing levels (SFHL and HFHL, respectively) were measured and log-transformed. Analysis of covariance was used. The prevalence rate of moderate or more hearing loss in the groups was estimated.RESULTS: In total, 194 men and 226 women participated. The ratio of means of SFHL and HFHL between PDR and controls was 0.18 and 0.20, respectively. Hearing loss was prevalent in severe NPDR/PDR (adjusted prevalence ratio 3.36 for SFHL and 1.51 for HFHL) compared to controls. Also, the prevalence of high-frequency hearing loss was more in mild-moderate NPDR (adjusted prevalence ratio 1.33).CONCLUSIONS: The magnitude of the increase in hearing impairment prevalence between the severe NPDR/PDR patients and controls was about 24% for both SFHL and HFHL. We recommend hearing assessment in the screening of the DR patients.

otorhinolaryngology
Diabetes mellitus as etiological factor of hearing loss

Clícia Adriana S. Maia,Carlos Alberto H. de Campos

DOI: https://doi.org/10.1016/s1808-8694(15)31312-4

IF: 2.474

2005-03-01

Brazilian Journal of Otorhinolaryngology

Abstract:Patients with diabetes mellitus often show symptoms such as dizziness, tinnitus, and hearing impairment. In general, hearing loss is sensorineural, which is sometimes confused with presbycusis, mainly because it develops in patients older than 40 years of age. Angiopathy and neuropathy caused by diabetes mellitus have been considered important factors for the vestibular-cochlear disorders found in these patients. However, there is controversy regarding the etiopathogenesis of hearing loss, as some researchers support that it develops due to neuropathy, others say it is due to angiopathy, or even a combination of both. Yet, some researchers believe diabetes mellitus and hearing loss are part of a genetic syndrome. We have conducted an extensive bibliographic review to determine whether there is cause-effect relationship between diabetes mellitus and hearing loss. We were able to verify that, despite the large number of studies performed, there is still a great deal of controversy, and new approaches are being studied, for example in the field of genetics, which shows that new paths can be followed to reach a conclusion on this issue.

otorhinolaryngology
Involvement of the auditory organ in type 1 diabetes mellitus.

A. Nowakowski,M. Dąbrowski,Grażyna Mielnik-Niedzielska

Endokrynologia Polska

Abstract:INTRODUCTION The aim of this study was to evaluate auditory organ function in relatively young type 1 diabetic patients, with short duration of the disease and without overt hearing loss. The impact of age, diabetes duration and metabolic control on hearing function was also analysed. MATERIAL AND METHODS Thirty-one patients with type 1 diabetes, aged below 45 years (mean 29.1 ± 7.1 years), with diabetes duration of less than 120 months (mean 54.7 ± 32.5 months), and no evident hearing impairment, were compared to 26 age-matched (30.3 ± 7.8 years, p = 0.567) healthy volunteers. In all subjects, pure-tone audiometry, transient evoked otoacoustic emissions (TEOAE), and auditory brainstem responses (ABR) were performed, after an ENT examination. RESULTS In diabetic patients, compared to healthy subjects, the mean hearing threshold in the pure-tone audiometry was significantly higher at high frequencies, the mean amplitude of TEOAE was lower (7.75 ± 4.43 dB v. 10.00 ± 4.01 dB, p < 0.001), and latency times of wave V and interval I-V in ABR were longer (5.78 ± 0.25 ms v. 5.69 ± 0.18 ms, p = 0.025 and 4.03 ± 0.20 ms v. 3.95 ± 0.17 ms, p = 0.017 respectively). In the diabetic group, the hearing threshold showed positive linear correlation with age, whereas TEOAE was inversely correlated with this parameter. In ABR latency, times of wave V and interval I-V were negatively correlated with diabetes duration. CONCLUSIONS This study confirms the involvement of the auditory organ in type 1 diabetes mellitus. To determine the prognostic and predictive values of this finding, and methods of possible prevention of hearing loss, further prospective observations are required.

Medicine
Impact of different modifiable factors on hearing function in type 1 and type 2 diabetic subjects. A preliminary study.

M. Dąbrowski,A. Nowakowski,Grażyna Mielnik-Niedzielska

2013-12-19

Annals of Agricultural and Environmental Medicine

Abstract:INTRODUCTION AND OBJECTIVE Hearing impairment in diabetic subjects is more prevalent than in the general population. Ageing, noise exposure and smoking are known as risk factors of hearing loss. The aim of this study was to assess whether other factors, such as HbA(1c), blood pressure, serum lipids and BMI have an impact on hearing function among relatively young diabetic subjects. MATERIALS AND METHODS 58 patients, 31 with type 1 diabetes and 27 with type 2 diabetes, aged < 45 years, with diabetes duration < 10 years and without overt hearing impairment were included. In all subjects, vital signs, laboratory tests, pure-tone audiometry and trancient-evoked otoacoustic emissions (TEOAE) were evaluated. RESULTS Hearing impairment was revealed in 20 subjects. This group had a lower HDL-cholesterol level compared with normal hearing patients (44.2 mg/dl vs. 57.6 mg/dl, p=0.007). Absence of otoacoustic emissions was diagnosed in 16 subjects. These patients also had a lower HDL-cholesterol level compared with subjects with TEOAE present (45.4 mg/dl vs. 55.2 mg/dl, p=0.018). Hearing threshold was inversely correlated with HDL-cholesterol level, and positively correlated with triglycerides. Patients with HDL-cholesterol level ≥50 mg/dl had lower hearing threshold at frequencies 0.5-12 kHz, as well as higher TEOAE amplitude. Subjects with triglycerides above median had a higher hearing threshold at frequencies 0.5-12 kHz, as well as lower TEOAE amplitude. Patients with elevated BMI (≥25 kg/m(2)) had a higher hearing threshold at frequencies 2-12 kHz, as well as lower TEOAE amplitude. CONCLUSIONS Hearing impairment is frequent among relatively young diabetic subjects. The preseted study reveals that factors like HDL-cholesterol, triglycerides, and BMI may affect hearing function in this group.

Medicine
Association of Thallium with Diabetes Risk among Patients with Hearing Loss: Result from NHANES 2013 to 2018

Jing Li,Zhi-Gang Lai,Xiao-Hua Huang

DOI: https://doi.org/10.1097/md.0000000000037317

IF: 1.6

2024-03-13

Medicine

Abstract:Hearing loss is the fourth leading contributor to years lived with disability, which represents a significant global health burden [ 1 ] About 1 billion young adults are at risk of hearing loss and there are 466 million individuals with disabling hearing loss worldwide reported by the World Health Organization. [ 2 ] Multiple factors such as aging, noise exposure, infection, and congenital may result in hearing loss. [ 1 ] It is evident that hearing loss presents close correlations with dementia, cognition, and risk for hospitalization, unemployment, and depression. [ 3–7 ] Diabetes as a chronic multisystem disease is characterized by elevated glucose levels in the blood and urine because of inadequate production or use of insulin. Approximately 460 million adults have diabetes with a global incidence of 6.4%, which is expected to reach 7.7% by 2030. [ 8 ] Diabetes is related to neuropathy, retinopathy, kidney disease, and cardiovascular disease. [ 2 ] Many patients with diabetes have a probability of developing hearing loss since high glucose levels may damage the vessels of the nerves and stria vascularis. [ 9 ] However, lack of research focus on the diabetes risk among patients with hearing loss. Clinically, hearing loss refers to a pure tone average >25 dB; however, hearing conditions vary widely across grades, and mild hearing loss may be reversible after self-healing or modifying incentives. [ 10 ] Thus, we adopted data on hearing conditions with severe hearing difficulty as study populations.

medicine, general & internal

Rare tumors: an eye on the future.

Neural cell recognition molecule F11: Homology with fibronectin type III and immunoglobulin type C domains

Diabetes mellitus and hearing loss: A review

AIDS, acyclovir and apocalypse.

Epidemiology of Diabetes and Hearing Loss

Risk Factors for Hearing Impairment Among U.S. Adults With Diabetes

1326-P: Diabetes Is Associated with a Higher Hearing Loss Risk in an Observational and Mendelian Randomization Study

Diabetes and Risk of Hearing Impairment in Adults: A Meta-Analysis

A systematic review of the association of Type I diabetes with sensorineural hearing loss

An association of type 1 diabetes mellitus with auditory dysfunction: A systematic review and meta-analysis

Hearing loss in type 1 diabetes: Are we facing another microvascular disease? A meta-analysis

Prevalence of Hearing Loss in Type 2 Diabetes Mellitus and Its Association with Severity of Diabetic Neuropathy

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.

A clinical study of audiological profile in diabetes mellitus patients

Effects of chitosan-stabilized selenium nanoparticles on cell proliferation, apoptosis and cell cycle pattern in HepG2 cells: comparison with other selenospecies.

Association of different severity of diabetic retinopathy and hearing loss in type 2 diabetes mellitus

Diabetes mellitus as etiological factor of hearing loss

Involvement of the auditory organ in type 1 diabetes mellitus.

Impact of different modifiable factors on hearing function in type 1 and type 2 diabetic subjects. A preliminary study.

Association of Thallium with Diabetes Risk among Patients with Hearing Loss: Result from NHANES 2013 to 2018